I believe this is a question often studied in Economics journals, you may want to look there. If I remember correctly, it is referred to as "Type I vs. Type II"

I believe this is a question often studied in Economics journals, you may want to look there. If I remember correctly, it is referred to as "Type I vs. Type II" error. One type of error is when a drug is approved prematurely and people are harmed because of it. The other type of error is when people are harmed because a useful drug is kept off the market. Some economists theorize that the second type of error would be more common, because the first kind of error is more visual and visceral. I believe there have been studies attempting to find evidence for the theory, but I'm not an expert and have never kept up with the latest journals in economics.